Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass

Method of reducing pulmonary hypertension and atrial fibrillation after surgery using cardiopulmonary bypass

US Patent 6011017 · Granted Jan 4, 2000

Estimated economic value: $673,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mechanical assemblies for a treadmill2025
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analg2001
Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analg2001
Medical use of fluorenone derivatives for treating and preventing brain and spin2001
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Injection of fructose-1,6-diphosphate (FDP) prior to coronary artery bypass graf2000
Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an anal2000
Treatment of sickle cell anemia crises with fructose-1, 6-diphosphate as an anal2000
Neuroprotective poly-guanidino compounds which block presynaptic N and P/Q calci2000
Use of fructose-1 6-diphosphate as an inotrope drug after cardiopulmonary bypass1999